FORA Capital’s AdaptHealth AHCO Stock Holding History

FORA Capital’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8,942	Closed	-$336K	–	749
2020 Q4	$336K	Buy	+8,942	New	+$277K	0.05%	379

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

FORA Capital's AHCO Position: Q1 2021 in Review

FORA Capital sold out of AdaptHealth (AHCO) in Q1 2021, closing a stake of 8,942 shares — an estimated $336K sold.

FORA Capital first reported a position in AHCO in Q4 2020 and held it in 1 quarter. The position peaked at $336K in Q4 2020. 145 funds tracked by Wall St. Rank hold AHCO as of Q1 2021.

FORA Capital reported no remaining AdaptHealth position as of Q1 2021 after selling out during the quarter.
FORA Capital sold 8,942 AdaptHealth shares in Q1 2021, an estimated $336K.
FORA Capital first reported a position in AdaptHealth in Q4 2020 and held it in 1 quarter.
FORA Capital's AdaptHealth position peaked at $336K in Q4 2020.
145 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2021.

Based on FORA Capital's 13F filing for Q1 2021, filed 17 May 2021.